Serious Variances Found in Pfizer COVID-19 Shot Batches

---

COPENHAGEN, DENMARK – As a result of emergency use authorizations and rapid rollout of vaccination programs abridging standard clinical trials, Danish scientists reviewed 52 batches of the Pfizer COVID-19 shot and found variations between them regarding the number of severe adverse events (SAE) reported after injection.

The study, published March 30 in the European Journal of Clinical Investigation, showed that out of nearly eight million COVID-19 shot doses administered in Denmark from December 2020 to January 2022, there were nearly 69,000 suspected adverse events across 52 different shot batches. In addition, more than 14,000 of those suspected events were classified as severe. The study used data available from the Danish Medical Agency, and other reporting systems, all akin to the Vaccine Adverse Event Reporting System (VAERS) used in the U.S.

The study showed a correlation between higher SAE occurrences according to a person’s batch number of those receiving two mRNA COVID-19 shot doses.

>Dr.Peter McCullough, an internist, epidemiologist, and one of the most published cardiologists in America, with over 1,000 publications and 660 citations in the National Library of Medicine, explained the Danish study found that “71% of serious adverse events came from 4.2% of doses.” McCullough noted that with more side effects associated with just a small percentage of the doses means the majority of COVID shot risks reside in the shot itself rather than the person receiving it.